AGM/EGMApr 30, 2026, 04:42 PM
RXRX 2026 Annual Meeting Set for June 17; Director Elections
AI Summary
Recursion Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 17, 2026. Stockholders as of the April 21, 2026 record date are eligible to vote on key proposals. These include the election of two Class II directors, an advisory vote on executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026.
Key Highlights
- RXRX to hold 2026 Annual Meeting of Stockholders virtually on June 17, 2026, at 12:00 P.M. Mountain Time.
- Stockholders of record as of April 21, 2026, are entitled to vote.
- Proposals include the election of two Class II directors to serve until the 2029 annual meeting.
- Shareholders will vote on an advisory basis to approve executive compensation.
- Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026.
- The Board of Directors consists of 10 members, with 8 out of 10 being independent directors.
Price Impact
More from RXRX